Liver Diseases  >>  Opdivo (nivolumab)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Opdivo (nivolumab) / BMS
MDX1106-02, NCT00703469: A Study of MDX-1106 to Treat Patients With Hepatitis C Infection

Completed
1
54
US
MDX1106-02, Placebo
Bristol-Myers Squibb
Hepatitis C
10/09
10/09

Download Options